NeoAdjuvant pembrolizumab and STEreotactic radiotherapy prior to nephrectomy for renal cell carcinoma (NAPSTER): A phase II randomised clinical trial-Reference-Cited by-同舟云学术

NeoAdjuvant pembrolizumab and STEreotactic radiotherapy prior to nephrectomy for renal cell carcinoma (NAPSTER): A phase II randomised clinical trial

Published:2023-06 Issue: Volume:33 Page:101145
ISSN:2451-8654
Container-title:Contemporary Clinical Trials Communications
language:en
Short-container-title:Contemporary Clinical Trials Communications

Author:

Ali Muhammad^ORCID,Wood Simon,Pryor David^ORCID,Moon Daniel^ORCID,Bressel Mathias,Azad Arun A.^ORCID,Mitchell Catherine^ORCID,Murphy Declan,Zargar Homi,Hardcastle Nick^ORCID,Kearsley Jamie,Eapen Renu,Wong Lih Ming,Cuff Katharine,Lawrentschuk Nathan,Neeson Paul J.,Siva Shankar

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference44 articles.

1. European association of Urology guidelines on renal cell carcinoma: the 2019 update;Ljungberg;Eur. Urol.,2019

2. Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Escudier;Ann. Oncol.,2019

3. Surveillance following radical or partial nephrectomy for renal cell carcinoma;Lam;Curr. Urol. Rep.,2005

4. Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma;Zisman;J. Clin. Oncol.,2002

5. Local recurrence following resection of intermediate-high risk nonmetastatic renal cell carcinoma: an anatomical classification and analysis of the ASSURE (ECOG-ACRIN E2805) adjuvant trial;Lee;J. Urol.,2020

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The investigational role of cytoreductive stereotactic ablative radiation therapy (SABR) to the primary tumor in metastatic kidney cancer;Expert Review of Anticancer Therapy;2024-05-02

2. Stereotactic ablative radiotherapy for primary renal cell carcinoma;Clinical and Translational Radiation Oncology;2024-01